Moreover, further expression analyses suggested a downregulation of CKMT2-AS1, SGMS1-AS1, and SNHG14 (Figure 10G, all p < 0.05) in bladder cancer. This evidence concerns the gene SGMS1 and urinary bladder carcinoma.